• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Kinases / Related Products
You are here: Product Lines > Signal Transduction > Kinases / Related Products
Toolbar - View Selection
 
 Items 100-120 of 623 Page 6 of 32 Select Page: << 1 2 3 4 5 6 7 8 9 10  >>  
ALX-201-224 Revised 22-Feb-06
cAMP-dependent Protein Kinase (Catalytic Subunit Cα) (mouse) (recombinant)
Add to Clipboard
SYNONYMS Protein Kinase A (Catalytic Subunit Cα) (mouse) (recombinant)
PKA (Catalytic Subunit Cα) (mouse) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PKA
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-224-C025   25 µg 305.00 USD Add To Cart
ALX-201-224-C050   50 µg 474.00 USD Add To Cart
ALX-201-224-C100   100 µg 812.00 USD Add To Cart
Product Specification
MW: ~41kDa
SOURCE/HOST: Produced in E. coli.
CONCENTRATION:  
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In 25mM potassium phosphate, pH 6.5, containing 5mM β-mercaptoethanol, 5mM EDTA, 150mM NaCl and 50% glycerol.
SPECIFIC ACTIVITY: 1.5x107U/mg. One unit is defined as the amount of enzyme required to incorporate 1pmol phosphate per min into the specific substrate kemptide (Prod. No. ALX-160-006) at 30°C.
APPLICATION: - In vitro enzymological studies of neural and hormonal signal transduction
- Phosphorylation of target proteins in vivo (via microinjection) including ion channels, transcriptional activator proteins and regulatory enzymes of glycogen metabolism
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Stable for 6 months after receipt when stored at -20°C. Stable for 2 weeks when stored at +4°C.
HANDLING: Avoid freeze/thaw cycles.
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-229 Revised 15-May-07
cAMP-dependent Protein Kinase (Holoenzyme Type IIα, Cα2 (mouse)/RIIα2 (human)) (recombinant)
Add to Clipboard
SYNONYMS Protein Kinase A (Holoenzyme Type IIα, Cα2 (mouse)/RIIα2 (human)) (recombinant)
PKA (Holoenzyme Type IIα, Cα2 (mouse)/RIIα2 (human)) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PKA
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-229-C020   20 µg 474.00 USD Add To Cart
ALX-201-229-C050   50 µg 812.00 USD Add To Cart
ALX-201-229-C100   100 µg 1'489.00 USD Add To Cart
Product Specification
MW: ~172kDa
SOURCE/HOST: Produced in E. coli.
CONCENTRATION: ~1mg/ml
FORMULATION: Liquid. In 20mM MOPS, pH 7.0, containing 150mM sodium chloride and 50% glycerol.
SPECIFIC ACTIVITY: 1.5x107U/mg (for the Cα catalytic subunit of the activated holoenzyme). One unit is defined as the amount of enzyme required to incorporate 1pmol phosphate per min into the specific substrate kemptide (Prod. No. ALX-160-006) at 30°C.
APPLICATION: Suitable for analyzing PKA type II agonists (cAMP analogs) or antagonists.
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at -20°C.
HANDLING: Avoid freeze/thaw cycles.
Product Description
Inactive holoenzyme consisting of one dimeric human regulatory subunit type IIα and two monomeric mouse catalytic subunits. Activate by addition of the second messenger cAMP (Ka~100nM) (Prod. No. ALX-480-011) releasing two monomeric catalytic subunits.
Product Specific Literature References
[1] Assays of protein kinase: R. Roskoski, Jr.; Meth. Enzymol. 99, 3 (1983) Abstract
[2] PrKX is a novel catalytic subunit of the cAMP-dependent protein kinase regulated by the regulatory subunit type I: B. Zimmermann, et al.; J. Biol. Chem. 274, 5370 (1999) Abstract; Full Text
General Information
BACKGROUND/TECHNICAL INFORMATION

Roskoski-Assay

Protein kinase activity may be measured by using a modified radioactive assay [1].
The assay is performed in a mixture containing 50mM MOPS, pH 7.0, 10mM MgCI2, 0.25mg/ml BSA, 100µM kemptide (peptide substrate), 100µM unlabeled ATP mixed with [γ-32p] ATP (500-1000cpm/pmol) in a final volume of 50µI. Reaction is started by addition of the Cα subunit from activated PKA holoenzyme, type IIα and can be stopped after a 5 min. incubation at 30°C by spotting the reaction mix onto Whatman® P-81 filters and soaking the filters four times in 75mM phosphoric acid (10ml per sample) for at least 5 min. After four washing steps rinse filters with ethanol, dry and count.
For the detection of phosphorylation in substrate proteins the phosphotransferase reaction can alternatively be stopped by taking aliquots of the mixture and adding SDS sample buffer. The phosphorylation status of the substrate proteins can subsequently be analysed using SDS PAGE and autoradiography [2].

Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-225 Revised 26-Jul-05
cAMP-dependent Protein Kinase (Regulatory Subunit RIα) (bovine) (recombinant)
Add to Clipboard
SYNONYMS Protein Kinase A (Regulatory Subunit RIα) (bovine) (recombinant)
PKA (Regulatory Subunit RIα) (bovine) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PKA
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-225-C025   25 µg 474.00 USD Add To Cart
ALX-201-225-C050   50 µg 812.00 USD Add To Cart
ALX-201-225-C100   100 µg 1'489.00 USD Add To Cart
Product Specification
MW: ~43kDa/subunit; homodimer
SOURCE/HOST: Produced in E. coli.
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In 10mM potassium phosphate, pH 6.8, containing 150mM NaCl, 14mM 2-mercaptoethanol, 1mM EDTA and 50% glycerol.
BIOLOGICAL ACTIVITY: Reversibly inhibits the catalytic subunit Cα of cAMP-dependent protein kinase (PKA) (Prod. No. ALX-201-224). The inhibition of the catalytic subunit can be reversed by the addition of the second messenger cAMP (>1µM) (Prod. No. ALX-480-011).
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Keep the glycerol stock solution of the enzyme permanently at -20°C while pipetting to avoid loss of inhibitory activity.
HANDLING: Avoid freeze/thaw cycles.
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-226 Revised 18-Jan-06
cAMP-dependent Protein Kinase (Regulatory Subunit RIIα) (human) (recombinant)
Add to Clipboard
SYNONYMS Protein Kinase A (Regulatory Subunit RIIα) (human) (recombinant)
PKA (Regulatory Subunit RIIα) (human) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PKA
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-226-C025   25 µg 474.00 USD Add To Cart
ALX-201-226-C050   50 µg 812.00 USD Add To Cart
ALX-201-226-C100   100 µg 1'489.00 USD Add To Cart
Product Specification
MW: 45kDa/subunit; homodimer
SOURCE/HOST: Produced in E. coli.
CONCENTRATION:  
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In 10mM potassium phosphate, pH 6.8, containing 150mM NaCl, 14mM β-mercaptoethanol, 1mM EDTA and 50% glycerol.
BIOLOGICAL ACTIVITY: Reversibly inhibits the catalytic subunit Cα of cAMP-dependent protein kinase (PKA) (Prod. No. ALX-201-224). The inhibition of the catalytic subunit can be reversed by the addition of the second messenger cAMP (>1µM) (Prod. No. ALX-480-011).
APPLICATION: Suitable for the analysis of interactions with so-called A-kinase anchoring proteins (AKAPs).
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Keep the glycerol stock solution of the enzyme permanently at -20°C while pipetting to avoid loss of inhibitory activity.
HANDLING: Avoid freeze/thaw cycles.
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-227 Revised 14-Nov-07
cAMP-dependent Protein Kinase (Regulatory Subunit RIIβ) (rat) (recombinant)
Add to Clipboard
SYNONYMS Protein Kinase A (Regulatory Subunit RIIβ) (rat) (recombinant)
PKA (Regulatory Subunit RIIβ) (rat) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PKA
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-227-C025   25 µg 474.00 USD Add To Cart
ALX-201-227-C050   50 µg 812.00 USD Add To Cart
ALX-201-227-C100   100 µg 1'489.00 USD Add To Cart
Product Specification
MW: 45kDa/subunit; homodimer
SOURCE/HOST: Produced in E. coli.
CONCENTRATION:           
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In 10mM potassium phosphate, pH 6.8, containing 150mM NaCl, 14mM 2-mercaptoethanol, 1mM EDTA and 50% glycerol.
BIOLOGICAL ACTIVITY: Reversibly inhibits the catalytic subunit Cα of cAMP-dependent protein kinase (PKA) (Prod. No. ALX-201-224). The inhibition of the catalytic subunit can be reversed by the addition of the second messenger cAMP (>1µM) (Prod. No. ALX-480-011).
APPLICATION: Suitable for inhibition studies and for the analysis of interactions with so-called A-kinase anchoring proteins (AKAPs).
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Keep the glycerol stock solution of the enzyme permanently at -20°C while pipetting to avoid loss of inhibitory activity.
HANDLING: Avoid freeze/thaw cycles.
General Literature References
cAMP signaling in neurons: patterns of neuronal expression and intracellular localization for a novel protein, AKAP 150, that anchors the regulatory subunit of cAMP-dependent protein kinase II beta: S.B. Glantz, et al.; Mol. Biol. Cell 3, 1215 (1992) Abstract
Cloning and expression of an intron-less gene for AKAP 75, an anchor protein for the regulatory subunit of cAMP-dependent protein kinase II beta: A.H. Hirsch, et al.; J. Biol. Chem. 267, 2131 (1992) Abstract
Regional localization of the regulatory subunit (RII beta) of the type II cAMP-dependent protein kinase in human brain: V. Licameli, et al.; Brain. Res. 578, 61 (1992) Abstract
Identification of a high affinity binding protein for the regulatory subunit RII beta of cAMP-dependent protein kinase in Golgi enriched membranes of human lymphoblasts: R.M. Rios, et al.; EMBO J. 11, 1723 (1992) Abstract
Characterization of distinct tethering and intracellular targeting domains in AKAP75, a protein that links cAMP-dependent protein kinase II beta to the cytoskeleton: S.B. Glantz, et al.; J. Biol. Chem. 268, 12796 (1993) Abstract
Phosphorylation of the regulatory subunit of type II beta cAMP-dependent protein kinase by cyclin B/p34cdc2 kinase impairs its binding to microtubule-associated protein 2: G. Keryer, et al.; PNAS 90, 5418 (1993) Abstract
Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton: Y. Li & C.S. Rubin; J. Biol. Chem. 270, 1935 (1995) Abstract
Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta: M. Nesterova, et al.; Eur. J. Biochem. 235, 486 (1996) Abstract
Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice: E.P. Brandon, et al.; J. Neurosci. 18, 3639 (1998) Abstract
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-228 Revised 07-Sep-05
cAMP-dependent Protein Kinase (Holoenzyme Type Iα, Cα2 (mouse)/RIα2 (bovine)) (recombinant)
Add to Clipboard
SYNONYMS Protein Kinase A (Holoenzyme Type Iα, Cα2 (mouse)/RIα2 (bovine)) (recombinant)
PKA (Holoenzyme Type Iα, Cα2 (mouse)/RIα2 (bovine)) (recombinant)
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PKA
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-228-C020   20 µg 474.00 USD Add To Cart
ALX-201-228-C050   50 µg 812.00 USD Add To Cart
ALX-201-228-C100   100 µg 1'489.00 USD Add To Cart
Product Specification
MW: ~168kDa
SOURCE/HOST: Produced in E. coli. Inactive holoenzyme consisting of one dimeric bovine regulatory subunit type Iα and two monomeric mouse catalytic subunits. Can be activated by adding the second messenger cAMP (Prod. No. ALX-480-011) releasing two monomeric catalytic subunits.
FORMULATION: Liquid. In 20mM MOPS, pH 7.0, containing 5mM MgCl2, 100µM ATP, 150mM NaCl and 50% glycerol.
SPECIFIC ACTIVITY: 1.5 x 107U/mg (for the Cα catalytic subunit of the activated holoenzyme). One unit is defined as the amount of enzyme required to incorporate 1pmol phosphate per min into the specific substrate kemptide (Prod. No. ALX-160-006) at 30°C.
APPLICATION: Suitable for analyzing PKA type I agonists (cAMP analogs) or antagonists.
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: In order to prevent dissociation of the holoenzyme complex use always buffer with 5-10mM MgCl2 and 0.1-1mM ATP.
HANDLING: Avoid freeze/thaw cycles.
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-153-003 Revised 03-Feb-05
Casein Kinase II Substrate
Add to Clipboard
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY Casein Kinase Substrates
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-153-003-M001   1 mg 70.00 USD Add To Cart
ALX-153-003-M005   5 mg 280.00 USD Add To Cart
Product Specification
SEQUENCE: H-Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu-OH
FORMULA: C52H87N19O24
MW: 1362.4
PURITY: ≥96%
APPEARANCE: White lyophilized powder.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
Product Description
Specific substrate for casein kinase II, derived from the kinase II phosphorylation site found in casein. Is not being phosphorylated by casein kinase I, cAMP-dependent protein kinase, protein kinase G, myosin light chain kinase, phosphorylase kinase and EGF receptor kinase.
Product Specific Literature References
A synthetic peptide substrate specific for casein kinase II: E.A. Kuenzel & E.D. Krebs; PNAS 82, 737 (1985) Abstract
Further Categories Containing This Product:
Peptides
 
 
ALX-270-442 Revised 21-Oct-08
CDK1/2 Inhibitor III
Add to Clipboard
SYNONYMS 5-Amino-3-((4-(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-442-M001   1 mg 118.00 USD Add To Cart
Product Specification
FORMULA: C15H13F2N7O2S2
MW: 425.4
CAS NUMBER: 443798-55-8
PURITY: ≥95% (HPLC)
APPEARANCE: White to off-white solid.
SOLUBILITY: Soluble in DMSO (10mg/ml), tetrahydro-furan or acetone.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
USE/STABILITY: Stock solutions are stable for up to 6 months when stored at -20°C.
HANDLING: Protect from light.
HAZARD: HARMFUL.
IDENTITY: Identity determined by NMR.

Product Description
Cell permeable triazolo-diamine compound that displays anti-proliferative properties in various human cancer cells (IC50=20nM, 35nM and 92nM in HCT-116, HeLa, and A375 cells). Acts as a highly potent, ATP-competitive inhibitor of CDK1/cyclin B and CDK2/cyclin A (IC50=600pM and 500pM) with selectivity over VEGF-R2 and GSK-3β (IC50=32nM and 140nM).
Product Specific Literature References
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities: R. Lin, et al.; J. Med. Chem. 48, 4208 (2005) Abstract
 
 
ALX-270-391 Revised 18-Jul-07
CGP 74514A
Add to Clipboard
SYNONYMS N-(cis-2-Aminocyclohexyl)-N-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-391-M001   1 mg 35.00 USD Add To Cart
ALX-270-391-M005   5 mg 70.00 USD Add To Cart
ALX-270-391-M025   25 mg 280.00 USD Add To Cart
Inquire
Product Specification
FORMULA: C19H24ClN7
MW: 385.9
PURITY: ≥95%
APPEARANCE: White to yellow solid.
SOLUBILITY: Soluble in DMSO.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Protect from light. Packaged under inert gas.

Product Description
Cell permeable, potent and selective inhibitor of CDK1/cyclin B (IC50=25nM). Reported to affect the activities of other kinases only at much higher concentrations: PKCα (IC50=6.1µM), PKA (IC50=125µM) and EGFR (IC50>10µM). Induces mitochondrial damage and apoptosis in several human leukemia cell lines (>3µM).
Product Specific Literature References
2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors: P. Imbach, et al.; Bioorg. Med. Chem. Lett. 9, 91 (1999) Abstract
The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process: C. Yu, et al.; Cancer Res. 63, 1822 (2003) Abstract
Further Categories Containing This Product:
Apoptosis Inducers & Inhibitors Other Products
 
 
ALX-350-008 Revised 02-Oct-07
Chelerythrine chloride
Add to Clipboard
SYNONYMS 1,2-Dimethoxy-N-methyl-[1,3]benzodioxolo[5,6-c]phenanthridinium chloride
PRODUCT LINE Natural Products / Antibiotics
PRODUCT CATEGORY Natural Products - Protein Kinase Inhibitors
Ordering Information